Stocks › KALV
KALV
KALV·USD
—
No end-of-day price on record
KALV
KALV
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
KALVS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of KALV by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
KALVKALV · Stock |
Purchase $1,001 - $15,000 |
Jan 20, 2023 | Dec 12, 2022 | Filing ↗ |
Whale Activity
Position changes in KALV reported for 2026-06-30 by 7 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed7
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0 | $0 | closed |
| VANGUARD CAPITAL MANAGEMENT LLC | 0 | $0 | closed |
| BlackRock, Inc. | 0 | $0 | closed |
| Point72 Asset Management | 0 | $0 | closed |
| Citadel Advisors LLC | 0 | $0 | closed |
| Millennium Management LLC | 0 | $0 | closed |
| Two Sigma Investments, LP | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by KALV insiders, by quarter · Form 4
Recent Insider Transactions
519 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Audhya Paul K.CHIEF MEDICAL OFFICER | Disposition to issuer | −150.3K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Disposition to issuer | −59.3K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Disposition to issuer | −21.7K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Disposition to issuer | −229.9K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Disposition to issuer | −480.0K | $0.00 | $0 | Jun 11, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −33.8K | $26.78 | $905K | May 27, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Option exercise | +33.8K | $7.07 | $239K | May 27, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,239 | $26.78 | $60K | May 26, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,489 | $26.78 | $40K | May 26, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −1,966 | $26.78 | $53K | May 26, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Option exercise | +5,000 | — | — | May 22, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Option exercise | +5,000 | — | — | May 22, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Option exercise | +3,125 | — | — | May 22, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Sale | −2,685 | $26.78 | $72K | May 22, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Sale | −1,861 | $26.78 | $50K | May 22, 2026 | Form 4 ↗ |
| Piekos BrianChief Financial Officer | Sale | −1,489 | $26.78 | $40K | May 22, 2026 | Form 4 ↗ |
| Yea ChristopherCHIEF DEVELOPMENT OFFICER | Sale | −2,358 | $26.78 | $63K | May 22, 2026 | Form 4 ↗ |
| Palleiko Benjamin LCHIEF EXECUTIVE OFFICER · Director | Sale | −10.9K | $26.78 | $293K | May 22, 2026 | Form 4 ↗ |
| Audhya Paul K.CHIEF MEDICAL OFFICER | Option exercise | +6,250 | — | — | May 21, 2026 | Form 4 ↗ |
| Sweeny NicoleChief Commercial Officer | Option exercise | +6,250 | — | — | May 21, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding KALV · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| SMALLCAP World Fund Inc | 2.8M | $56.5M | 0.07% | Mar 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $27.2M | 0.00% | Mar 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.1M | $21.7M | 0.29% | Mar 31, 2026 |
| iShares Russell 2000 ETF iSHARES TRUST | 942.6K | $19.0M | 0.03% | Mar 31, 2026 |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 690.6K | $18.6M | 2.20% | May 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 379.1K | $10.1M | 0.03% | Apr 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 439.5K | $8.8M | 0.01% | Mar 31, 2026 |
| SmallCap Growth Fund I Principal Funds, Inc | 321.1K | $8.6M | 0.36% | Apr 30, 2026 |
| Nomura Small Cap Growth Fund IVY FUNDS | 353.3K | $7.1M | 0.72% | Mar 31, 2026 |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 260.1K | $6.9M | 0.49% | Apr 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list KALV's shares (CUSIP 483497103), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Paul J. GlazerSCHEDULE 13G · passive (13G) · 2.6M shares4.8%
Jun 10, 2026 · ↗ - Glazer Capital, LLCSCHEDULE 13G · passive (13G) · 2.6M shares4.8%
Jun 10, 2026 · ↗ - FHMLS XI, L.L.C.SCHEDULE 13D/A · activist (13D) · 145.6K shares0.8%
May 21, 2026 · ↗ - FHMLS XI, L.P.SCHEDULE 13D/A · activist (13D) · 145.6K shares0.3%
May 21, 2026 · ↗ - Frazier Life Sciences XI, L.P.SCHEDULE 13D/A · activist (13D) · 145.6K shares0.3%
May 21, 2026 · ↗ - FHMLS X, L.L.C.SCHEDULE 13D/A · activist (13D) · 428.0K shares0.8%
May 21, 2026 · ↗ - FHMLS X, L.P.SCHEDULE 13D/A · activist (13D) · 428.0K shares0.8%
May 21, 2026 · ↗ - Frazier Life Sciences X, L.P.SCHEDULE 13D/A · activist (13D) · 428.0K shares0.8%
May 21, 2026 · ↗ - FHMLSP, L.L.C.SCHEDULE 13D/A · activist (13D) · 1.2M shares2.3%
May 21, 2026 · ↗ - FHMLSP, L.P.SCHEDULE 13D/A · activist (13D) · 1.2M shares2.3%
May 21, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming KALV as client
No lobbying filings found naming KALV as the client.
Government Contracts
Federal awards to KALV · USAspending
No federal contract awards found for KALV.
U.S. Patents
Recent USPTO applications naming KALV
No USPTO patent applications found for KALV.
Annual Financials
From KALV's 10-K filings · XBRL
No annual XBRL figures on record for KALV. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-14Reverse splitNov 22, 2016
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01Material agreement · Termination of agreement · Acquisition or dispositionJun 11, 2026
EDGAR ↗
About KALV
From SEC EDGAR company records
No company profile on record.